TB and COVID-19: paying attention to diabetes mellitus. (27th February 2021)

• Record Type: Journal Article
• Authors: Harries, Anthony D; Kumar, Ajay M V; Satyanarayana, Srinath; Lin, Yan; Dlodlo, Riitta A; Khogali, Mohammed; Zachariah, Rony; Kapur, Anil
• Is Part Of: Transactions of the Royal Society of Tropical Medicine and Hygiene. Volume 115:Number 6(2021)
• Page Start: 600
• Page End: 602
• Publication Date: 2021-02-27
• Subjects: COVID-19 -- diabetes mellitus -- SARS-CoV-2 -- TB; Tropical medicine -- Periodicals; 616.9883
• DOI: 10.1093/trstmh/trab035
• Languages: English
• ISSNs: 0035-9203

Abstract

Abstract: In 2019, global diabetes prevalence was 463 million. Diabetes increases the risk of TB and adverse treatment outcomes including death and relapse. Diabetes also increases the risk of severe disease, multi-organ failure, coagulopathy and death in COVID-19. TB and COVID-19 share many features, suggesting opportunities to integrate prevention, diagnosis and care. Three areas for further work are highlighted: better infection control in diabetes clinics, easier and quicker diagnosis using similar technology platforms and optimal blood glucose control. The funding and resources for COVID-19 should be harnessed to improve TB and diabetes care and achieve their respective sustainable development goal targets.